loader
slider1

Successfully conductedmore than 5000 studies globally

LEARN MORE
slider2

60 years of Dermatology experience

LEARN MORE
slider3

Leading Biosimilars experience

LEARN MORE
slider4

More than Two Million Samples analyzed LC/MS/MS & ELISA using methods

LEARN MORE
slider5

50 Phase I-IV Oncology studiesconducted in past
5 years using methods

LEARN MORE
slider6

Full Service Biometricson major platforms
including kTrials

LEARN MORE

About Cliantha

Welcome to the Cliantha Research group of companies. Cliantha is a global Contract Research Organization (CRO) providing integrated clinical offerings in Early Phase (Phase I/IIa ), Late Phase (Phase II-IV), Bioequivalence (BA/BE), Clinical Endpoint Trials, Bioanalytical, Biosimilars, Dermatology, Biometrics, and Personal Healthcare services. Our services have science at its foundation that is developed through regular and systematic training of the Cliantha team.

Cliantha offers Biosimilar, Biotech, Cosmetic, Generic, Personal Healthcare and Pharmaceutical companies a comprehensive range of clinical research and support services. You will notice we use our legacy brand names: Cliantha Research, Hill Top Research and Karmic Lifesciences, however, we operate as one company – Cliantha. We have added and enhanced the capabilities during the past 5 years in each of the companies to provide our sponsors with a single, global research network.

Regulatory Inspections

Last Inspection in Nov 2015
Inspected facility in Nov 2006
Inspected facility in Jan 2009
Last inspection in Apr-May 2016
Inspected facility in Feb - Mar 2013
Last inspection in March 2013
Inspected facility in July 2013
Last inspected by Ministry of Health of Turkey in April 2013
Last inspection in Apr-May 2016

News & Events

3-7 March
2017

The American Academy of Dermatology's Annual Meeting

Cliantha Research will be attending The American Academy of Dermatology's Annual Meeting, to be held in Orlando, Fla., March 3-7, 2017.

Learn More
23 Oct
2016

Biosimilars Bioanalysis; Challenges and Solutions

Dr. Shaifali Gupta, Laboratory Director, presented on ‘Biosimilars Bioanalysis; Challenges and Solutions’ - at the 49th Annual Conference...

Learn More
19 Oct
2016

Adis journal, Drug Safety; Volume 39, Issue 10, October 2016

Dr. Shaifali Gupta, Laboratory Director, presented at the 16th Annual Conference of International Society of Pharmacovigilance held at Agra on the 19th October 2016...

Learn More
19 Apr
2016

CMIA based clinical lab instrument

Dr. Shaifali Gupta, Laboratory Director, presented the poster titled "Challenges in estimation of FSH for pharmacokinetic...

Learn More

Case Studies

Biosimilars Case Studies

Learn More

Nitroglycerine Study

Learn More

Potassium Chloride KCL study

Learn More